Literature DB >> 26889033

Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.

Teru Kanda1, Yuki Furuse2, Hitoshi Oshitani2, Tohru Kiyono3.   

Abstract

UNLABELLED: The Epstein-Barr virus (EBV) is etiologically linked to approximately 10% of gastric cancers, in which viral genomes are maintained as multicopy episomes. EBV-positive gastric cancer cells are incompetent for progeny virus production, making viral DNA cloning extremely difficult. Here we describe a highly efficient strategy for obtaining bacterial artificial chromosome (BAC) clones of EBV episomes by utilizing a CRISPR/Cas9-mediated strand break of the viral genome and subsequent homology-directed repair. EBV strains maintained in two gastric cancer cell lines (SNU719 and YCCEL1) were cloned, and their complete viral genome sequences were determined. Infectious viruses of gastric cancer cell-derived EBVs were reconstituted, and the viruses established stable latent infections in immortalized keratinocytes. While Ras oncoprotein overexpression caused massive vacuolar degeneration and cell death in control keratinocytes, EBV-infected keratinocytes survived in the presence of Ras expression. These results implicate EBV infection in predisposing epithelial cells to malignant transformation by inducing resistance to oncogene-induced cell death. IMPORTANCE: Recent progress in DNA-sequencing technology has accelerated EBV whole-genome sequencing, and the repertoire of sequenced EBV genomes is increasing progressively. Accordingly, the presence of EBV variant strains that may be relevant to EBV-associated diseases has begun to attract interest. Clearly, the determination of additional disease-associated viral genome sequences will facilitate the identification of any disease-specific EBV variants. We found that CRISPR/Cas9-mediated cleavage of EBV episomal DNA enabled the cloning of disease-associated viral strains with unprecedented efficiency. As a proof of concept, two gastric cancer cell-derived EBV strains were cloned, and the infection of epithelial cells with reconstituted viruses provided important clues about the mechanism of EBV-mediated epithelial carcinogenesis. This experimental system should contribute to establishing the relationship between viral genome variation and EBV-associated diseases.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26889033      PMCID: PMC4836357          DOI: 10.1128/JVI.00060-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data.

Authors:  Chen-Shan Chin; David H Alexander; Patrick Marks; Aaron A Klammer; James Drake; Cheryl Heiner; Alicia Clum; Alex Copeland; John Huddleston; Evan E Eichler; Stephen W Turner; Jonas Korlach
Journal:  Nat Methods       Date:  2013-05-05       Impact factor: 28.547

2.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

3.  The E1 protein of human papillomavirus type 16 is dispensable for maintenance replication of the viral genome.

Authors:  Nagayasu Egawa; Tomomi Nakahara; Shin-Ichi Ohno; Mako Narisawa-Saito; Takashi Yugawa; Masatoshi Fujita; Kenji Yamato; Yukikazu Natori; Tohru Kiyono
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

4.  EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

Authors:  Hiroshi Kimura; Yoshinori Ito; Shinji Kawabe; Kensei Gotoh; Yoshiyuki Takahashi; Seiji Kojima; Tomoki Naoe; Shinichi Esaki; Atsushi Kikuta; Akihisa Sawada; Keisei Kawa; Koichi Ohshima; Shigeo Nakamura
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

5.  Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains.

Authors:  Zhen Lin; Xia Wang; Michael J Strong; Monica Concha; Melody Baddoo; Guorong Xu; Carl Baribault; Claire Fewell; William Hulme; Dale Hedges; Christopher M Taylor; Erik K Flemington
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

6.  Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees.

Authors:  K Tamura; M Nei
Journal:  Mol Biol Evol       Date:  1993-05       Impact factor: 16.240

7.  Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1.

Authors:  Do Nyun Kim; Min Koo Seo; Hoyun Choi; Su Yeon Kim; Hee Jong Shin; A-Ran Yoon; Qian Tao; Sun Young Rha; Suk Kyeong Lee
Journal:  J Gen Virol       Date:  2012-11-21       Impact factor: 3.891

8.  High-efficiency targeted editing of large viral genomes by RNA-guided nucleases.

Authors:  Yanwei Bi; Le Sun; Dandan Gao; Chen Ding; Zhihua Li; Yadong Li; Wei Cun; Qihan Li
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

9.  Engineering large viral DNA genomes using the CRISPR-Cas9 system.

Authors:  Tadahiro Suenaga; Masako Kohyama; Kouyuki Hirayasu; Hisashi Arase
Journal:  Microbiol Immunol       Date:  2014-09       Impact factor: 1.955

10.  Generation of mutant mice by pronuclear injection of circular plasmid expressing Cas9 and single guided RNA.

Authors:  Daisuke Mashiko; Yoshitaka Fujihara; Yuhkoh Satouh; Haruhiko Miyata; Ayako Isotani; Masahito Ikawa
Journal:  Sci Rep       Date:  2013-11-27       Impact factor: 4.379

View more
  25 in total

Review 1.  Phylogenetic comparison of Epstein-Barr virus genomes.

Authors:  Su Jin Choi; Seok Won Jung; Sora Huh; Hyosun Cho; Hyojeung Kang
Journal:  J Microbiol       Date:  2018-06-14       Impact factor: 3.422

Review 2.  A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System.

Authors:  Anna Bellizzi; Nicholas Ahye; Gauthami Jalagadugula; Hassen S Wollebo
Journal:  J Neuroimmune Pharmacol       Date:  2019-09-11       Impact factor: 4.147

Review 3.  Epstein-Barr virus: more than 50 years old and still providing surprises.

Authors:  Lawrence S Young; Lee Fah Yap; Paul G Murray
Journal:  Nat Rev Cancer       Date:  2016-09-30       Impact factor: 60.716

Review 4.  Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape.

Authors:  Martyn K White; Wenhui Hu; Kamel Khalili
Journal:  PLoS Pathog       Date:  2016-12-08       Impact factor: 6.823

5.  Highly Efficient CRISPR/Cas9-Mediated Homologous Recombination Promotes the Rapid Generation of Bacterial Artificial Chromosomes of Pseudorabies Virus.

Authors:  Jin-Chao Guo; Yan-Dong Tang; Kuan Zhao; Tong-Yun Wang; Ji-Ting Liu; Jia-Cong Gao; Xiao-Bo Chang; Hong-Yu Cui; Zhi-Jun Tian; Xue-Hui Cai; Tong-Qing An
Journal:  Front Microbiol       Date:  2016-12-23       Impact factor: 5.640

6.  IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma.

Authors:  Ji Wook Moon; Su-Kang Kong; Byung Soo Kim; Hyun Ji Kim; Hyangsoon Lim; Kyeonga Noh; Younghye Kim; Jung-Woo Choi; Ju-Han Lee; Young-Sik Kim
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

Review 7.  EBV and Apoptosis: The Viral Master Regulator of Cell Fate?

Authors:  Leah Fitzsimmons; Gemma L Kelly
Journal:  Viruses       Date:  2017-11-13       Impact factor: 5.048

Review 8.  CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.

Authors:  Arinze Okoli; Malachy I Okeke; Morten Tryland; Ugo Moens
Journal:  Viruses       Date:  2018-01-22       Impact factor: 5.048

9.  Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection.

Authors:  Zhong Zou; Kun Huang; Yanmin Wei; Huanchun Chen; Ziduo Liu; Meilin Jin
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

10.  The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.

Authors:  Ming-Han Tsai; Xiaochen Lin; Anatoliy Shumilov; Katharina Bernhardt; Regina Feederle; Remy Poirey; Annette Kopp-Schneider; Bruno Pereira; Raquel Almeida; Henri-Jacques Delecluse
Journal:  Oncotarget       Date:  2017-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.